Abstract The invention provides novel antibiotic compounds which are 7β-acylamidoceph-3-em-4-carboxylic acids, and non-toxic derivatives thereof characterized in that the acylamido group has the structure ##STR1## where R is a hydrogen atom or an organic group and R a is an etherifying monovalent organic group linked to the oxygen atom through a carbon atom. The compounds are syn isomers or exist as mixtures containing at least 75% of the syn isomer. These antibiotic compounds possess high antibacterial activity against a range of gram positive and gram negative organisms coupled with particularly high stability to β-lactamases produced by various gram negative organisms. The invention is also concerned with the administration of the compounds.
A compound selected from the group consisting of a cephalosporin antibiotic highly stable to β-lactamases having the formula ##STR148## wherein R is phenyl, thienyl or furyl and R a is C 1 -C 8 alkyl or benzyl; and a physiologically acceptable salt thereof.
Claim 2
Dependent Claim
43 words
A compound selected from the group consisting of a cephalosporin antibiotic highly stable to β-lactamases having the formula ##STR148## wherein R is phenyl, thienyl or furyl and R a is C 1 -C 8 alkyl or benzyl; and a physiologically acceptable salt thereof.
Claim 3
Dependent Claim
11 words
The compound of claim 1 which is sodium 3-hydroxymethyl-7β-(2-methoxyimino-2-phenylacetamido)ceph-3-em-4-carboxylate (syn isomer).